SHMSF yields 3478.26% · PFE yields 6.13%● Live data
📍 SHMSF pulled ahead of the other in Year 1
Combined, SHMSF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SHMSF + PFE for your $10,000?
Shimao Services Holdings Limited, an investment holding company, provides property management and community living services in the People's Republic of China. It operates in two segments, Property Management and Related Services; and City Services. The company offers property management services, including security, cleaning, greening and gardening, repair, and maintenance services to construction, gardening, and other property management companies. It also provides community value added services, such as community asset management, carpark asset operation, campus value-added, and retail services; sells hardware devices and software products; and home decoration services, including supply chain services of decoration materials, and marketing and promotion services to property owners and developers, technology companies, and other property management companies. In addition, the company offers value-added services, which comprise display units and property sales venue management, preliminary planning and design consultancy, and repair and maintenance management services to property developers; and city services that include sanitation, cleaning, and sewage and waste treatment. Further, it is involved in the real estate agency, wholesale and retail trading, construction decoration and other construction, education, enterprises management consulting, household management, engineering construction, and hotel management businesses. The company was founded in 2005 and is headquartered in Shanghai, the People's Republic of China. Shimao Services Holdings Limited is a subsidiary of Best Cosmos Limited.
Full SHMSF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.